Intratumoral bleomycin and IL-12 electrochemogenetherapy for treating head and neck tumors in dogs.

Jeffry Cutrera, Marina Torrero, Keijiro Shiomitsu, Neal Mauldin, Shulin Li

Research output: Contribution to journalArticlepeer-review

41 Scopus citations

Abstract

Bleomycin and Interleukin 12 have been used clinically to treat tumors; however, the co-administration of Bleomycin and Interleukin 12 followed by electroporation has not been tested clinically. In this study, dogs with spontaneous head and neck tumors were treated with one co-administration of Bleomycin and Interleukin 12 plasmid DNA followed by electroporation. The regression of the recurrent papillary tumor and the adjacent metastatic bone tumor was analyzed by multiple CT scans. The papillary tumor was completely eradicated in less than 2 weeks, and the bone tumor was not visible 23 weeks after the administration.

Original languageEnglish (US)
Pages (from-to)319-325
Number of pages7
JournalMethods in molecular biology (Clifton, N.J.)
Volume423
DOIs
StatePublished - 2008

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Fingerprint

Dive into the research topics of 'Intratumoral bleomycin and IL-12 electrochemogenetherapy for treating head and neck tumors in dogs.'. Together they form a unique fingerprint.

Cite this